Zeng Hao: Meet the Experts of VIRO 2025

The Global Voices in Renal Oncology (VIRO) Virtual Congress, organized by OncoDaily, will be held on September 11–12, 2025. Chaired by Dr. Rana R. McKay with co-chair Dr. Yüksel Ürün, this year’s program will feature around 50 leading experts in renal oncology from across the globe, sharing cutting-edge updates and future perspectives.

• The congress is free to attend.
• Register via the link.

Co-Chair of VIRO

Images

Name

Rana McKay Professor of Medicine and Urology at UC San Diego Health Co-leader of the GU Oncology Program at Moores Cancer Center As Co-Chair of VIRO, Dr. Rana McKay (University of California, San Diego) opened the congress with her talk on  “Future Directions: Emerging Agents and Combinations.” She emphasized the momentum in renal cell carcinoma (RCC) research, highlighting how novel immunotherapies, targeted drugs, and rational combination strategies are reshaping patient care. Dr. McKay underscored the importance of personalized, biomarker-driven approaches and global collaboration, aiming to optimize survival and quality of life worldwide.

Spotlight on Zeng Hao

Dr. Zeng Hao is a Professor of Urology at West China Hospital, Sichuan University, one of the leading centers for urological care and research in China.

At the Global Voices in Renal Oncology (VIRO) Virtual Congress 2025, Dr. Zeng will present on “The Current State of Renal Oncology in China.” His presentation will cover:

• The landscape of renal cancer diagnosis, treatment, and research in China.
• Advances in robotic surgery, minimally invasive approaches, and multidisciplinary care at West China Hospital.
• Challenges and opportunities within China’s healthcare system to improve renal cancer outcomes.
• Ongoing clinical trials and innovations shaping the future of renal oncology in China.

Dr. Zeng Hao brings a comprehensive clinical and academic perspective, emphasizing regional expertise alongside cutting-edge therapeutic advances to enhance patient care in Chinese renal oncology.

Global Voices in Renal Oncology (VIRO) 2025